Naphthannelated azepinones: Synthesis and antitumor activity

Pharmazie

Volumn 54, Issue 9, 1999, Pages 645-650

  Bleeker, C ^a   Kunick, C ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO 5H BENZO[B]NAPHTH[2,3 E]AZEPIN 6(13H) ONE; 2 BROMO 5H BENZO[B]NAPHTH[2,3 E]AZEPINE 6,13 DIONE; 4H NAPHTHO[2,3 E]THIENO[3,2 B]AZEPINE 5,12 DIONE; 5H BENZO[B]NAPHTH[2,3 E]AZEPIN 6,13 DIONE; 6H BENZO[E]NAPHTH[2,3 B]AZEPINE 7,12 DIONE; ANTINEOPLASTIC AGENT; AZEPINE DERIVATIVE; NAPHTHALENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY;

ANTINEOPLASTIC AGENTS; AZEPINES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; TUMOR CELLS, CULTURED;

EID: 0032868494     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zaharevitz, D. W.; Gussio, R.; Jalluri, R. K.; Sausville, E. A.; Kunick, C.; Meijer, L.: US Pat. Appl, 60/089, 619 (1998)
2. Link, A.; Kunick, C.: Synthesis 297 (1997)
3. Link, A.; Kunick, C.: J. Med. Chem. 41, 1299 (1998)
4. Link, A.; Zaharevitz, D. W.; Kunick, C.: Pharmazie 54, 163 (1999)
5. Umemiya, H.; Fukasawa, H.; Ebisawa, M.; Eyrolles, L.; Kawachi, E.; Eisenmann, G.; Gronemeyer, H.; Hashimoto, Y.; Shudo, K.; Kagechika, H.: J. Med. Chem. 40, 4222 (1997)
6. Verine, A.; Lepage, Y.: Bull. Soc. Chim. Fr. 1154 (1973)
7. Serpaud, B.; Lepage, Y.: Bull. Soc. Chim. Fr. 539 (1977)
8. Mallouli, A.; Lepage, Y.: Synthesis 689 (1980)
9. Loudon, J. D.; Sloan, A. D. B.: J. Chem. Soc. 3262 (1962)
10. Thiele, J.; Schneider, J.: Liebigs Ann. Chem. 369, 287 (1909)
11. Thiele, J.; Wanscheidt, A.: Liebigs Ann. Chem. 376, 269 (1910)
12. Corbellini, A.; Cecchi, A.: Gazz. Chim. Ital. 63, 489 (1933)
13. Cava, M. P.; Levinson, M. I.: Tetrahedron 41, 5061 (1985)
14. Paull, K. D.; Shoemaker, R. H.; Hodes, L.; Monks, A.; Scudiero, D. A.; Rubinstein, L.; Plowman, J.; Boyd, M. R.: J. Natl. Cancer Inst. 81, 1088 (1989)
15. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M.: J. Natl. Cancer Inst. 83, 757 (1991)
16. Weinstein, J. N.; Myers, T. G.; O'Connor, P. M.; Friend, S. H.; Fornace, A. J. Jr.; Kohn, K. W.; Fojo, T.; Bates, S. E.; Rubinstein, L. V.; Anderson, N. L.; Buolamwini, J. K.; van Osdol, W. W.; Monks, A. P.; Scudiero, D. A.; Sausville, E. A.; Zaharevitz, D.W.; Bunow, B.; Viswanadhan, V. N.; Johnson, G. S.; Wittes, R. E.; Paull, K. D.: Science 275, 343 (1997)
17. Grever, M. R.; Schepartz, S. A.; Chabner, B. A.: Semin. Oncol. 19, 622 (1992)
18. Monks, A.; Scudiero, D. A.; Johnson, G. S.; Paull, K. D.; Sausville, E. A.: Anti-Cancer Drug Des. 12, 533 (1997)
19. Weislow, O. S.; Kiser, R.; Fine, D. L.; Bader, J.; Shoemaker, R. H.; Boyd, M. R.: J. Natl. Cancer Inst. 81, 577 (1989)
20. Kunick, C.: Arch. Pharm. (Weinheim) 324, 579 (1991)